Affiliation:
1. Department of Endoscopy, Fukushima Medical
University Hospital, Fukushima, Japan
2. Department of Gastroenterology, Fukushima
Medical University School of Medicine, Fukushima, Japan
3. Department of Advanced Gastrointestinal
Endoscopy, Fukushima Medical University, Fukushima, Japan
Abstract
Abstract
Background and study aims The safety and efficacy of endoscopic submucosal
dissection (ESD) for early gastric cancer (EGC) in very elderly patients remains
unclear. The aim of this study was to evaluate the safety and efficacy of ESD
for EGC in patients age 85 years and older.
Patients and methods Patients who underwent ESD for EGC between September
2003 and April 2015 were divided into 3 groups: the very elderly (≥ 85 years; 43
patients), the elderly (65 – 84 years; 511 patients), and the non-elderly ( ≤ 64
years; 161 patients). Adverse events (AEs) were used as the primary endpoint to
assess the safety of ESD, and the ESD treatment outcomes (i. e., en bloc
resection rate, complete en bloc resection rate, and curative resection
rate) and the overall survival rate after ESD were the secondary endpoints.
These parameters were retrospectively evaluated in the 3 groups.
Results There were no significant differences in AEs (non-elderly,
elderly, and very elderly: 7.3, 9.5, and 12.5 %, respectively, P = 0.491)
or in the en bloc resection and complete en bloc resection rates
among the three groups. However, there was a significant difference in the
curative resection rates (non-elderly, elderly, and very elderly: 91.5, 84.1,
and 77.1 %, respectively, P = 0.014). Regarding overall survival, there
was a significant difference among the three groups (1-, 5-, and 10-year overall
survival rates: non-elderly: 98.6, 90.2, and 74.7 %; elderly: 97.2, 86.2, and
61.9 %; and very elderly: 92.7, 66.8, and 34.4 %, respectively,
P = 0.001). Moreover, the overall survival rate in the very elderly
patients with cardiovascular disease was significantly lower than that in the
very elderly patients without cardiovascular disease (P < 0.001).
Conclusions ESD is an acceptable treatment for EGC in patients 85 years of
age or older in terms of safety. However, the overall survival after ESD in the
very elderly patients with cardiovascular disease was
short.
Subject
Gastroenterology,Medicine (miscellaneous)